Skip to main content

Table 3 Self-reported adherence among ASCVD patients taking part in cross-sectional study in MSF clinics, north Lebanon

From: Cardiovascular Disease among Syrian refugees: a descriptive study of patients in two Médecins Sans Frontières clinics in northern Lebanon

Drug

Overall (%, 95CI)

Abdeh clinic (%, 95 CI)

DAZ clinic (%, 95 CI)

ACE-I

83.8 [79.1, 87.6]

90.8 [85.2, 94.5]

75.2 [67.1, 81.9]

Statin

78.4 [74.4, 81.9]

91.2 [86.5, 94.4]

67.7 [61.7, 73.1]

Antiplatelet

93.9 [91.3, 95.8]

95.6 [91.7, 97.7]

92.5 [88.5, 95.2]

β—blocker

90.8 [87.4, 93.4]

94.1 [75.2, 87.4]

88.3 [83.2, 92.1]

Statin, antiplatelet, ACE-I

69.5 [64.0, 74.6]

82.0 [75.2, 87.4]

54.4 [45.7, 62.8]

Statin, antiplatelet, ACE-I/BB

72.6 [67.2, 77.5]

85.2 [78.7, 90.0]

57.3 [48.5, 65.5]

Back to article page

Conflict and Health

ISSN: 1752-1505